G. Grant Welstead

G. Grant Welstead is a highly experienced professional in the field of biophysics and immunology. Currently serving as the Vice President at Clade Therapeutics, Grant leads a team focused on developing innovative immune cell therapies. Prior to this role, Grant held positions at Editas Medicine, where G. Grant played key roles in the creation of NK cell therapy and novel cell therapeutics through CRISPR gene editing. With a Ph.D. from the University of Toronto, Grant's expertise ranges from genetics and stem cell research to course instruction at institutions like MIT. Grant's career has been marked by a dedication to scientific excellence and product development with a patient-centered approach.